<DOC>
	<DOC>NCT00167921</DOC>
	<brief_summary>The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin速 Vaginal Cream compared with Premarin速 oral tablets in postmenopausal women with atrophic vaginitis.</brief_summary>
	<brief_title>Study Comparing Premarin速 Vaginal Cream Versus Premarin速 Oral Tablets in Atrophic Vaginitis</brief_title>
	<detailed_description />
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<criteria>Generally healthy postmenopausal women. Intact uterus. Clinical diagnosis of moderate to severe atrophic vaginitis.</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>